Positron emission tomography to locate primary tumor in patients with cervical lymph node metastases from an occult tumor

被引：0
作者：
Schipper, JH
Schrader, M
Arweiler, D
Muller, S
Sciuk, J
机构：
来源：
HNO | 1996年 / 44卷 / 05期
关键词：
CUP syndrome; fluoro-18-deoxyglucose; positron emission tomography;
D O I：
暂无
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
In a prospective study 16 patients with cervical lymph node metastases from an occult tumor were analyzed by (F-18)FDG positron emission tomography (PET). The aim of this study was to locate the primary tumor. In 7 patients a localized increase in activity was seen on PET, with this site of activity histologically proven in 4 patients. No biopsies were taken in 3 patients in areas with a high risk of complications. In a follow-up procedure at 2-22 months after primary radiation therapy in the other 9 patients, no primary tumor has been identified to date.
引用
收藏
页码：254 / 257
页数：6
相关论文
共 50 条
[21]   A case of cerebral metastases of unknown origin - Utility of F-18FDG positron emission tomography to localize the primary tumor [J].
Belhocine, T ;
Bolle, S ;
Alberini, JL ;
Daenen, F ;
Rutten, I ;
Rigo, P .
CLINICAL NUCLEAR MEDICINE, 2001, 26 (09) :793-793
[22]   Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer [J].
Seol, Hee Yun ;
Kim, Yun Seong ;
Kim, Seong-Jang .
ONCOLOGY, 2021, 99 (02) :96-104
[23]   Isolated Mediastinal Lymph Node False Positivity of [18F]-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Patients With Cervical Cancer [J].
Onal, Cem ;
Oymak, Ezgi ;
Findikcioglu, Alper ;
Reyhan, Mehmet .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (02) :337-342
[24]   Imaging of tumor glucose utilization with positron emission tomography [J].
Andrea Buerkle ;
Wolfgang A. Weber .
Cancer and Metastasis Reviews, 2008, 27
[25]   Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II [J].
Fink, AM ;
Holle-Robatsch, S ;
Herzog, N ;
Mirzaei, S ;
Rappersberger, K ;
Lilgenau, N ;
Jurecka, W ;
Steiner, A .
MELANOMA RESEARCH, 2004, 14 (02) :141-145
[26]   Imaging of tumor glucose utilization with positron emission tomography [J].
Buerkle, Andrea ;
Weber, Wolfgang A. .
CANCER AND METASTASIS REVIEWS, 2008, 27 (04) :545-554
[27]   Lymph node staging for urinary bladder carcinoma with positron emission tomography (PET) [J].
Bachor, R ;
Kotzerke, J ;
Reske, SN ;
Hautmann, R .
UROLOGE-AUSGABE A, 1999, 38 (01) :46-50
[28]   DISTINGUISHING TUMOR RECURRENCE FROM IRRADIATION SEQUELAE WITH POSITRON EMISSION TOMOGRAPHY IN PATIENTS TREATED FOR LARYNX CANCER [J].
GREVEN, KM ;
WILLIAMS, DW ;
KEYES, JW ;
MCGUIRT, WF ;
HARKNESS, BA ;
WATSON, NE ;
RABEN, M ;
FRAZIER, LC ;
GEISINGER, KR ;
CAPPELLARI, JO .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (04) :841-845
[29]   Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation study [J].
Roh, JW ;
Seo, SS ;
Lee, S ;
Kang, KW ;
Kim, SK ;
Sim, JS ;
Kim, JY ;
Hong, EK ;
Cho, DS ;
Lee, JS ;
Park, SY .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (14) :2086-2092
[30]   F-18-FDG for detecting occult primary tumors in patients with lymph node metastases in the neck. [J].
Bohuslavizki, KH ;
Klutmann, S ;
Sonnemann, U ;
Thoms, J ;
Kröger, S ;
Werner, JA ;
Mester, J ;
Clausen, M .
LARYNGO-RHINO-OTOLOGIE, 1999, 78 (08) :445-449
12345